866-997-4948(US-Canada Toll Free)

Global Pemetrexed Drug Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

Published By :

Globalinforesearch

Published Date : Jan 2019

Category :

Pharmaceutical

No. of Pages : 121 Pages

Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.

Scope of the Report:
The global Pemetrexed Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pemetrexed Drug.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Pemetrexed Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pemetrexed Drug market by product type and applications/end industries.

Market Segment by Companies, this report covers
Eli Lilly and Company
Pfizer
Teva
Eagle Pharmaceuticals
APOTEX
Qilu Pharmaceutical
Biocon

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
100 mg lyophilized powder/vial
500 mg lyophilized powder/vial

Market Segment by Applications, can be divided into
Pleural mesothelioma
Non-small cell lung cancer
Table of Contents

1 Pemetrexed Drug Market Overview
1.1 Product Overview and Scope of Pemetrexed Drug
1.2 Classification of Pemetrexed Drug by Types
1.2.1 Global Pemetrexed Drug Revenue Comparison by Types (2019-2024)
1.2.2 Global Pemetrexed Drug Revenue Market Share by Types in 2018
1.2.3 100 mg lyophilized powder/vial
1.2.4 500 mg lyophilized powder/vial
1.3 Global Pemetrexed Drug Market by Application
1.3.1 Global Pemetrexed Drug Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Pleural mesothelioma
1.3.3 Non-small cell lung cancer
1.4 Global Pemetrexed Drug Market by Regions
1.4.1 Global Pemetrexed Drug Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Pemetrexed Drug Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Pemetrexed Drug Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pemetrexed Drug Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Pemetrexed Drug Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pemetrexed Drug Status and Prospect (2014-2024)
1.5 Global Market Size of Pemetrexed Drug (2014-2024)
2 Manufacturers Profiles
2.1 Eli Lilly and Company
2.1.1 Business Overview
2.1.2 Pemetrexed Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly and Company Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Pemetrexed Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
2.3 Teva
2.3.1 Business Overview
2.3.2 Pemetrexed Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
2.4 Eagle Pharmaceuticals
2.4.1 Business Overview
2.4.2 Pemetrexed Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eagle Pharmaceuticals Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
2.5 APOTEX
2.5.1 Business Overview
2.5.2 Pemetrexed Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 APOTEX Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
2.6 Qilu Pharmaceutical
2.6.1 Business Overview
2.6.2 Pemetrexed Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Qilu Pharmaceutical Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
2.7 Biocon
2.7.1 Business Overview
2.7.2 Pemetrexed Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Biocon Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pemetrexed Drug Market Competition, by Players
3.1 Global Pemetrexed Drug Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Pemetrexed Drug Players Market Share
3.2.2 Top 10 Pemetrexed Drug Players Market Share
3.3 Market Competition Trend
4 Global Pemetrexed Drug Market Size by Regions
4.1 Global Pemetrexed Drug Revenue and Market Share by Regions
4.2 North America Pemetrexed Drug Revenue and Growth Rate (2014-2019)
4.3 Europe Pemetrexed Drug Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Pemetrexed Drug Revenue and Growth Rate (2014-2019)
4.5 South America Pemetrexed Drug Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Pemetrexed Drug Revenue and Growth Rate (2014-2019)
5 North America Pemetrexed Drug Revenue by Countries
5.1 North America Pemetrexed Drug Revenue by Countries (2014-2019)
5.2 USA Pemetrexed Drug Revenue and Growth Rate (2014-2019)
5.3 Canada Pemetrexed Drug Revenue and Growth Rate (2014-2019)
5.4 Mexico Pemetrexed Drug Revenue and Growth Rate (2014-2019)
6 Europe Pemetrexed Drug Revenue by Countries
6.1 Europe Pemetrexed Drug Revenue by Countries (2014-2019)
6.2 Germany Pemetrexed Drug Revenue and Growth Rate (2014-2019)
6.3 UK Pemetrexed Drug Revenue and Growth Rate (2014-2019)
6.4 France Pemetrexed Drug Revenue and Growth Rate (2014-2019)
6.5 Russia Pemetrexed Drug Revenue and Growth Rate (2014-2019)
6.6 Italy Pemetrexed Drug Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Pemetrexed Drug Revenue by Countries
7.1 Asia-Pacific Pemetrexed Drug Revenue by Countries (2014-2019)
7.2 China Pemetrexed Drug Revenue and Growth Rate (2014-2019)
7.3 Japan Pemetrexed Drug Revenue and Growth Rate (2014-2019)
7.4 Korea Pemetrexed Drug Revenue and Growth Rate (2014-2019)
7.5 India Pemetrexed Drug Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Pemetrexed Drug Revenue and Growth Rate (2014-2019)
8 South America Pemetrexed Drug Revenue by Countries
8.1 South America Pemetrexed Drug Revenue by Countries (2014-2019)
8.2 Brazil Pemetrexed Drug Revenue and Growth Rate (2014-2019)
8.3 Argentina Pemetrexed Drug Revenue and Growth Rate (2014-2019)
8.4 Colombia Pemetrexed Drug Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Pemetrexed Drug by Countries
9.1 Middle East and Africa Pemetrexed Drug Revenue by Countries (2014-2019)
9.2 Saudi Arabia Pemetrexed Drug Revenue and Growth Rate (2014-2019)
9.3 UAE Pemetrexed Drug Revenue and Growth Rate (2014-2019)
9.4 Egypt Pemetrexed Drug Revenue and Growth Rate (2014-2019)
9.5 Nigeria Pemetrexed Drug Revenue and Growth Rate (2014-2019)
9.6 South Africa Pemetrexed Drug Revenue and Growth Rate (2014-2019)
10 Global Pemetrexed Drug Market Segment by Type
10.1 Global Pemetrexed Drug Revenue and Market Share by Type (2014-2019)
10.2 Global Pemetrexed Drug Market Forecast by Type (2019-2024)
10.3 100 mg lyophilized powder/vial Revenue Growth Rate (2014-2024)
10.4 500 mg lyophilized powder/vial Revenue Growth Rate (2014-2024)
11 Global Pemetrexed Drug Market Segment by Application
11.1 Global Pemetrexed Drug Revenue Market Share by Application (2014-2019)
11.2 Pemetrexed Drug Market Forecast by Application (2019-2024)
11.3 Pleural mesothelioma Revenue Growth (2014-2019)
11.4 Non-small cell lung cancer Revenue Growth (2014-2019)
12 Global Pemetrexed Drug Market Size Forecast (2019-2024)
12.1 Global Pemetrexed Drug Market Size Forecast (2019-2024)
12.2 Global Pemetrexed Drug Market Forecast by Regions (2019-2024)
12.3 North America Pemetrexed Drug Revenue Market Forecast (2019-2024)
12.4 Europe Pemetrexed Drug Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Pemetrexed Drug Revenue Market Forecast (2019-2024)
12.6 South America Pemetrexed Drug Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Pemetrexed Drug Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Table

List of Tables and Figures

Figure Pemetrexed Drug Picture
Table Product Specifications of Pemetrexed Drug
Table Global Pemetrexed Drug and Revenue (Million USD) Market Split by Product Type
Figure Global Pemetrexed Drug Revenue Market Share by Types in 2018
Figure 100 mg lyophilized powder/vial Picture
Figure 500 mg lyophilized powder/vial Picture
Table Global Pemetrexed Drug Revenue (Million USD) by Application (2014-2024)
Figure Pemetrexed Drug Revenue Market Share by Applications in 2018
Figure Pleural mesothelioma Picture
Figure Non-small cell lung cancer Picture
Table Global Market Pemetrexed Drug Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Pemetrexed Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Pemetrexed Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Pemetrexed Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Pemetrexed Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Pemetrexed Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Pemetrexed Drug Revenue (Million USD) and Growth Rate (2014-2024)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Pemetrexed Drug Type and Applications
Table Eli Lilly and Company Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Pemetrexed Drug Type and Applications
Table Pfizer Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Pemetrexed Drug Type and Applications
Table Teva Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Eagle Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Eagle Pharmaceuticals Pemetrexed Drug Type and Applications
Table Eagle Pharmaceuticals Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
Table APOTEX Basic Information, Manufacturing Base and Competitors
Table APOTEX Pemetrexed Drug Type and Applications
Table APOTEX Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Qilu Pharmaceutical Pemetrexed Drug Type and Applications
Table Qilu Pharmaceutical Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Pemetrexed Drug Type and Applications
Table Biocon Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Global Pemetrexed Drug Revenue (Million USD) by Players (2014-2019)
Table Global Pemetrexed Drug Revenue Share by Players (2014-2019)
Figure Global Pemetrexed Drug Revenue Share by Players in 2017
Figure Global Pemetrexed Drug Revenue Share by Players in 2018
Figure Global Top 5 Players Pemetrexed Drug Revenue Market Share in 2018
Figure Global Top 10 Players Pemetrexed Drug Revenue Market Share in 2018
Figure Global Pemetrexed Drug Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Pemetrexed Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Pemetrexed Drug Revenue Market Share by Regions (2014-2019)
Figure Global Pemetrexed Drug Revenue Market Share by Regions (2014-2019)
Figure Global Pemetrexed Drug Revenue Market Share by Regions in 2018
Figure North America Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Europe Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure South America Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Table North America Pemetrexed Drug Revenue by Countries (2014-2019)
Table North America Pemetrexed Drug Revenue Market Share by Countries (2014-2019)
Figure North America Pemetrexed Drug Revenue Market Share by Countries (2014-2019)
Figure North America Pemetrexed Drug Revenue Market Share by Countries in 2018
Figure USA Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Canada Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Mexico Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Table Europe Pemetrexed Drug Revenue (Million USD) by Countries (2014-2019)
Figure Europe Pemetrexed Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Pemetrexed Drug Revenue Market Share by Countries in 2018
Figure Germany Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure UK Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure France Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Russia Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Italy Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Pemetrexed Drug Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Pemetrexed Drug Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Pemetrexed Drug Revenue Market Share by Countries in 2018
Figure China Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Japan Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Korea Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure India Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Table South America Pemetrexed Drug Revenue by Countries (2014-2019)
Table South America Pemetrexed Drug Revenue Market Share by Countries (2014-2019)
Figure South America Pemetrexed Drug Revenue Market Share by Countries (2014-2019)
Figure South America Pemetrexed Drug Revenue Market Share by Countries in 2018
Figure Brazil Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Argentina Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Colombia Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Pemetrexed Drug Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Pemetrexed Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pemetrexed Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Pemetrexed Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure UAE Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Egypt Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure Nigeria Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Figure South Africa Pemetrexed Drug Revenue and Growth Rate (2014-2019)
Table Global Pemetrexed Drug Revenue (Million USD) by Type (2014-2019)
Table Global Pemetrexed Drug Revenue Share by Type (2014-2019)
Figure Global Pemetrexed Drug Revenue Share by Type (2014-2019)
Figure Global Pemetrexed Drug Revenue Share by Type in 2019
Table Global Pemetrexed Drug Revenue Forecast by Type (2019-2024)
Figure Global Pemetrexed Drug Market Share Forecast by Type (2019-2024)
Figure Global 100 mg lyophilized powder/vial Revenue Growth Rate (2014-2019)
Figure Global 500 mg lyophilized powder/vial Revenue Growth Rate (2014-2019)
Table Global Pemetrexed Drug Revenue by Application (2014-2019)
Table Global Pemetrexed Drug Revenue Share by Application (2014-2019)
Figure Global Pemetrexed Drug Revenue Share by Application (2014-2019)
Figure Global Pemetrexed Drug Revenue Share by Application in 2019
Table Global Pemetrexed Drug Revenue Forecast by Application (2019-2024)
Figure Global Pemetrexed Drug Market Share Forecast by Application (2019-2024)
Figure Global Pleural mesothelioma Revenue Growth Rate (2014-2019)
Figure Global Non-small cell lung cancer Revenue Growth Rate (2014-2019)
Figure Global Pemetrexed Drug Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Pemetrexed Drug Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Pemetrexed Drug Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Pemetrexed Drug Revenue Market Forecast (2019-2024)
Figure Europe Pemetrexed Drug Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Pemetrexed Drug Revenue Market Forecast (2019-2024)
Figure South America Pemetrexed Drug Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Pemetrexed Drug Revenue Market Forecast (2019-2024)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *